ATE350025T1 - Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel - Google Patents

Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel

Info

Publication number
ATE350025T1
ATE350025T1 AT04706141T AT04706141T ATE350025T1 AT E350025 T1 ATE350025 T1 AT E350025T1 AT 04706141 T AT04706141 T AT 04706141T AT 04706141 T AT04706141 T AT 04706141T AT E350025 T1 ATE350025 T1 AT E350025T1
Authority
AT
Austria
Prior art keywords
sodium
mercaptoethanesulphonate
antiviral agent
agent
antiviral
Prior art date
Application number
AT04706141T
Other languages
English (en)
Inventor
Fabio Piazza
Giorgio Conti
Pietro Portincasa
Carlo Zini
Original Assignee
Fabio Piazza
Giorgio Conti
Pietro Portincasa
Carlo Zini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabio Piazza, Giorgio Conti, Pietro Portincasa, Carlo Zini filed Critical Fabio Piazza
Application granted granted Critical
Publication of ATE350025T1 publication Critical patent/ATE350025T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04706141T 2003-02-04 2004-01-29 Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel ATE350025T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000175A ITMI20030175A1 (it) 2003-02-04 2003-02-04 Uso del 2-mercaptoetansolfonato di sodio come agente antivirale

Publications (1)

Publication Number Publication Date
ATE350025T1 true ATE350025T1 (de) 2007-01-15

Family

ID=32843891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04706141T ATE350025T1 (de) 2003-02-04 2004-01-29 Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel

Country Status (7)

Country Link
US (1) US20060189688A1 (de)
EP (1) EP1596851B1 (de)
AT (1) ATE350025T1 (de)
DE (1) DE602004004085T2 (de)
ES (1) ES2280941T3 (de)
IT (1) ITMI20030175A1 (de)
WO (1) WO2004069235A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
WO2016159684A1 (ko) * 2015-04-01 2016-10-06 주식회사 아모레퍼시픽 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물
AU2022405530A1 (en) * 2021-12-07 2024-07-11 Cila Therapeutic Inc. Anti-viral therapeutic agents and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119721A (en) * 1965-05-07 1968-07-10 Ucb Sa Mucolytic mercapto-sulphonates
DE3728917A1 (de) * 1987-08-29 1989-03-09 Roth Hermann J Neue lipide mit unsymmetrisch substituierter disulfidbruecke
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
CA2875298A1 (en) * 1999-12-09 2001-06-14 Medimmune, Inc. In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)

Also Published As

Publication number Publication date
DE602004004085D1 (de) 2007-02-15
ITMI20030175A1 (it) 2004-08-05
US20060189688A1 (en) 2006-08-24
EP1596851B1 (de) 2007-01-03
DE602004004085T2 (de) 2007-09-27
WO2004069235A1 (en) 2004-08-19
ES2280941T3 (es) 2007-09-16
EP1596851A1 (de) 2005-11-23

Similar Documents

Publication Publication Date Title
BRPI0414593A (pt) derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1
NO20091976L (no) Nye forbindelser
DE60310576D1 (en) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
UY3402Q (es) Diseno de tractor
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
UY3450Q (es) Botella
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
BRPI0414599A (pt) pirrol-indóis substituìdos
EA200701918A1 (ru) Белок липокалин
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
ATE247726T1 (de) Gezielte elektrochemische reduktion von halogenierten 4-amino-picolinsäuren
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK1585737T3 (da) Uraciler med herbicid virkning
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
UY3375Q (es) Esponja
DE50208918D1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE375978T1 (de) Benzoylsulfonamide als antitumor-mittel
UY28344A1 (es) Nuevos compuestos
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
DE60321484D1 (de) Aktivitätsüberwachung
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
SE0301654D0 (sv) Novel compounds
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы
ATE350025T1 (de) Verwendung von natrium-2-mercaptoethansulphonat als antivirales mittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties